Literature DB >> 30643933

10 myths about frusemide.

Michael Joannidis1, Sebastian J Klein2, Marlies Ostermann3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30643933     DOI： 10.1007/s00134-018-5502-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

Review 1.  Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug.

Authors:  Filippo Mariano; Alberto Mella; Marco Vincenti; Luigi Biancone
Journal:  J Nephrol       Date:  2019-05-14       Impact factor: 3.902

Review 2.  Diuretics and the kidney.

Authors:  R Bell; R Mandalia
Journal:  BJA Educ       Date:  2022-04-20

3.  Comparison of Losartan and Furosemide Interaction with HSA and Their Influence on HSA Antioxidant Potential.

Authors:  Wojciech Rogóż; Jadwiga Pożycka; Aleksandra Owczarzy; Karolina Kulig; Małgorzata Maciążek-Jurczyk
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-19

4.  Association Between Furosemide Exposure and Clinical Outcomes in a Retrospective Cohort of Critically Ill Children.

Authors:  Xiaomei Dai; Jiao Chen; Wenjing Li; Zhenjiang Bai; Xiaozhong Li; Jian Wang; Yanhong Li
Journal:  Front Pediatr       Date:  2021-01-25       Impact factor: 3.418

5.  Clinical Usefulness of Furosemide to Prevent Volume Overload Among Children and Young Adults with Transfusion-Dependent Thalassemia: A Randomized, Open-Label, Crossover Study.

Authors:  Apichat Photia; Chanchai Traivaree; Chalinee Monsereenusorn; Piyarat Simthamnimit; Piya Rujkijyanont
Journal:  J Blood Med       Date:  2020-12-29

6.  Drug-induced kidney injury in Chinese critically ill pediatric patients.

Authors:  Biwen Hu; Ling Ye; Tong Li; Zeying Feng; Longjian Huang; Chengjun Guo; Li He; Wei Tan; Guoping Yang; Zhiling Li; Chengxian Guo
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.